Analytical Data
-
Gene name
CMBL
- Application
-
Alternative Names
CMBL;Carboxymethylenebutenolidase homolog
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96DG6
-
Expression Region
2-245aa
-
AA Sequence
ANEAYPCPC DIGHRLEYGG LGREVQVEHI KAYVTKSPVD AGKAVIVIQD IFGWQLPNTR YIADMISGNG YTTIVPDFFV GQEPWDPSGD WSIFPEWLKT RNAQKIDREI SAILKYLKQQ CHAQKIGIVG FCWGGTAVHH LMMKYSEFRA GVSVYGIVKD SEDIYNLKNP TLFIFAENDV VIPLKDVSLL TQKLKEHCKV EYQIKTFSGQ THGFVHRKRE DCSPADKPYI DEARRNLIEW LNKYM
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CMBL, or Carboxymethylated Bovine Lactoferrin, is a recombinant protein derived from bovine lactoferrin, which is a multifunctional glycoprotein found in milk and other bodily fluids. It possesses various biological activities, including antimicrobial, antioxidant, and immunomodulatory properties, making it a subject of interest in biomedical research. The process of recombinant protein technology allows for the production of CMBL in a controlled environment, ensuring consistent quality and functionality. Researchers have been investigating the potential applications of CMBL in various fields, including nutrition, pharmaceuticals, and therapeutics, due to its ability to enhance iron absorption, support gut health, and modulate immune responses. Studies have also explored its role in preventing infections and inflammatory diseases, as well as its potential as a co-adjuvant in vaccine formulations. Given the increasing demand for functional foods and biopharmaceuticals, the investigation of CMBL offers promising avenues for innovation in health and disease management. Understanding its mechanisms of action and optimizing its production could lead to new strategies for improving health outcomes, particularly in populations with specific nutritional needs or compromised immune systems. The ongoing research into CMBL aims to elucidate its biological interactions and enhance its applications in clinical settings, contributing to the advancement of functional protein-based therapies.
